Illumina, Inc. (ILMN)
207.01
-2.54
(-1.21%)
USD |
NASDAQ |
Nov 13, 16:00
207.03
+0.02
(+0.01%)
After-Hours: 19:59
Illumina Market Cap : 31.47B for Nov. 13, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 13, 2026 | 31.47B |
| November 12, 2026 | 31.85B |
| November 11, 2026 | 32.37B |
| November 10, 2026 | 32.67B |
| November 09, 2026 | 33.56B |
| November 06, 2026 | 32.40B |
| November 05, 2026 | 31.62B |
| November 04, 2026 | 34.43B |
| November 03, 2026 | 36.21B |
| November 02, 2026 | 34.44B |
| October 30, 2026 | 35.87B |
| October 29, 2026 | 44.09B |
| October 28, 2026 | 43.90B |
| October 27, 2026 | 42.48B |
| October 26, 2026 | 40.93B |
| October 23, 2026 | 40.68B |
| October 22, 2026 | 40.68B |
| October 21, 2026 | 42.71B |
| October 20, 2026 | 40.46B |
| October 19, 2026 | 39.66B |
| October 16, 2026 | 39.64B |
| October 15, 2026 | 40.46B |
| October 14, 2026 | 41.04B |
| October 13, 2026 | 40.95B |
| October 12, 2026 | 41.78B |
| Date | Value |
|---|---|
| October 09, 2026 | 42.00B |
| October 08, 2026 | 39.95B |
| October 07, 2026 | 40.43B |
| October 06, 2026 | 41.30B |
| October 05, 2026 | 44.35B |
| October 02, 2026 | 41.23B |
| October 01, 2026 | 40.12B |
| September 30, 2026 | 41.33B |
| September 29, 2026 | 41.07B |
| September 28, 2026 | 41.06B |
| September 25, 2026 | 40.77B |
| September 24, 2026 | 41.36B |
| September 23, 2026 | 38.56B |
| September 22, 2026 | 37.37B |
| September 21, 2026 | 36.06B |
| September 18, 2026 | 36.18B |
| September 17, 2026 | 37.02B |
| September 16, 2026 | 34.57B |
| September 15, 2026 | 33.57B |
| September 14, 2026 | 31.44B |
| September 11, 2026 | 31.17B |
| September 10, 2026 | 30.39B |
| September 09, 2026 | 30.96B |
| September 08, 2026 | 31.87B |
| September 04, 2026 | 32.95B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Agilent Technologies, Inc. | 49.05B |
| Thermo Fisher Scientific, Inc. | 259.44B |
| Bio-Rad Laboratories, Inc. | 9.852B |
| Danaher Corp. | 163.91B |
| QIAGEN NV | 10.30B |
Market Cap Related Metrics
| PE Ratio | 35.57 |
| PS Ratio | 7.007 |
| PEG Ratio | 1.170 |
| Price to Book Value | 10.00 |
| Price to Free Cash Flow | 49.97 |
| Price | 207.01 |
| Earnings Yield | 2.81% |
| PEGY Ratio | 1.170 |
| Operating PE Ratio | 33.82 |
| Normalized PE Ratio | 40.65 |